Literature DB >> 7246527

Serum cholesterol and mortality: the Yugoslavia Cardiovascular Disease Study.

D Kozarevic, D McGee, N Vojvodic, T Gordon, Z Racic, W Zukel, T Dawber.   

Abstract

The relationship of level of baseline serum cholesterol to the seven-year incidence of death from all causes and from specific causes was examined in a cohort of 11,121 Yugoslav males aged 35--62 years at the time of their initial examination (1964--1965). Serum cholesterol was negatively related to mortality, i.e., those with a lower cholesterol experienced a higher mortality than those with a higher cholesterol. The negative relationship was significant (as assessed by logistic regression) and remained significant after adjusting for obesity, systolic blood pressure, cigarette smoking, age, history of intestinal parasitism, and socioeconomic status (as measured by years of education). The negative association of serum cholesterol and subsequent mortality appeared to be due to the relationship of cholesterol to deaths due to cancer and to deaths due to respiratory disease (tuberculosis and cor pulmonale). The cancer death-serum cholesterol relationship was not statistically significant but the respiratory disease death-serum cholesterol relationship was. Serum cholesterol, as expected, was positively related to the incidence of coronary heart disease death.

Entities:  

Keywords:  Age Factors; Biology; Cancer; Causes Of Death; Cholesterol; Demographic Factors; Developed Countries; Europe; Heart Diseases; Lipids; Mortality--men; Physiology; Population; Population Dynamics; Pulmonary Effects; Southern Europe; Yugoslavia

Mesh:

Substances:

Year:  1981        PMID: 7246527     DOI: 10.1093/oxfordjournals.aje.a113170

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  The Origins and Early Evolution of Epidemiologic Research in Cardiovascular Diseases: A Tabular Record of Cohort and Case-Control Studies and Preventive Trials Initiated From 1946 to 1976.

Authors:  Henry Blackburn
Journal:  Am J Epidemiol       Date:  2019-01-01       Impact factor: 4.897

Review 2.  Plasma cholesterol, lipid lowering, and risk for cancer. An update of the results from epidemiologic studies and intervention trials.

Authors:  K J Lackner; G Schettler; W Kübler
Journal:  Klin Wochenschr       Date:  1989-09-15

Review 3.  The complex interplay between cholesterol and prostate malignancy.

Authors:  Keith R Solomon; Michael R Freeman
Journal:  Urol Clin North Am       Date:  2011-06-22       Impact factor: 2.241

4.  Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism.

Authors:  Mi-Jeong Kim; Helen C Wainwright; Michael Locketz; Linda-Gail Bekker; Gabriele B Walther; Corneli Dittrich; Annalie Visser; Wei Wang; Fong-Fu Hsu; Ursula Wiehart; Liana Tsenova; Gilla Kaplan; David G Russell
Journal:  EMBO Mol Med       Date:  2010-07       Impact factor: 12.137

5.  Premature mortality in middle-aged men: serum cholesterol as risk factor.

Authors:  B Peterson; E Trell
Journal:  Klin Wochenschr       Date:  1983-08-15

6.  Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies.

Authors:  M R Law; S G Thompson
Journal:  Cancer Causes Control       Date:  1991-07       Impact factor: 2.506

7.  Is the use of cholesterol in mortality risk algorithms in clinical guidelines valid? Ten years prospective data from the Norwegian HUNT 2 study.

Authors:  Halfdan Petursson; Johann A Sigurdsson; Calle Bengtsson; Tom I L Nilsen; Linn Getz
Journal:  J Eval Clin Pract       Date:  2011-09-25       Impact factor: 2.431

8.  Male gender and duration of anti-tuberculosis treatment are associated with hypocholesterolemia in adult pulmonary tuberculosis patients in Kampala, Uganda.

Authors:  John Mukisa; Ismael Kawooya; Joan Nangendo; Annet Nalutaaya; Jean Nyamwiza; Ali Sam; Ronald Ssenyonga; William Worodria; Ezekiel Mupere
Journal:  Afr Health Sci       Date:  2018-09       Impact factor: 0.927

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.